-
Oct 16, 2024 | 
lexology.com | Bart Van Vooren |Yuliya Gevrenova |Zoé Bertrand
October 12, 2024, marks the 10-year anniversary of entry into force of the Nagoya Protocol on Access to Genetic Resources and Fair Benefit-Sharing from their Utilization (“ABS”). This additional treaty to the Convention on Biological Diversity (“CBD”) has now been ratified by 142 countries. Over the past decade, Nagoya Protocol has resulted in the mushrooming of more than one-hundred thirty (130+) national ABS laws around the globe.
-
Oct 9, 2024 | 
lexology.com | Bart Van Vooren |Yuliya Gevrenova |Zoé Bertrand
I. About the Upcoming Decision on the ‘DSI Tax’On 1 November 2024, the 196 countries that are party to the Convention on Biological Diversity (“CBD”) may agree on the terms and conditions of the “multilateral mechanism (“MLM”) for benefit-sharing from the use of digital sequence information.” The purpose of this mechanism is to extract funds from the private sector to finance recovery and preservation of Earth’s biodiversity.
-
Apr 17, 2024 | 
academic.oup.com | Institut Bergonié |Bart Van Vooren |Bouvy JC
Precision oncology (PO) uses molecular, phenotypic, and health data from cancer patients to target treatment and improve health outcomes.1 Genomic and molecular alterations are increasingly important in cancer diagnosis, and scientific advances are opening new treatment avenues.
-
Feb 8, 2024 | 
lexology.com | Bart Van Vooren |Lucas Michel |Valeria Sturla
All questionsYear in reviewIn 2023, the Belgian Minister for Social Affairs continued working on healthcare expenditure and adopted measures to incentivise the uptake of biosimilars in Belgium, which continues to be very low compared to many other EU Member States.
-
Feb 8, 2024 | 
lexology.com | Bart Van Vooren |Lucas Michel |Valeria Sturla
All questionsIntroductionBelgium is a European Union (EU) Member State and has thus implemented the EU medicines and medical devices regimes. This chapter will not repeat the substantive content of the EU chapter but instead will focus on unique features of the Belgian regime. It should be read in conjunction with the EU chapter.
-
Feb 1, 2024 | 
lexblog.com | Candido Garcia Molyneux |Bart Van Vooren |Rosa Oyarzabal
Rosa Oyarzabal Arigita is an associate in the Life Sciences team. She assists clients across a range of regulatory, legal and procedural matters in the pharmaceutical and food sectors, and her practice focuses on EU and Spanish regulatory advice. Rosa has acquired significant experience in the pharmaceutical advertising space, both at EU level as well in Member States such as Spain and Belgium.
-
Jan 31, 2024 | 
lexblog.com | Bart Van Vooren |Rosa Oyarzabal |Candido Garcia Molyneux |Sean Finan
On January 17, 2024, the European Parliament formally endorsed its provisional agreement with the Council on the Directive Empowering Consumers for the Green Transition through Better Protection against Unfair Practices and Better Information (“Greenwashing Directive”). The Council is now expected to endorse the provisional agreement after which the Directive will be published in the EU Official Journal and enter into force.
-
Jan 31, 2024 | 
lexology.com | Bart Van Vooren |Rosa Oyarzabal |Candido Garcia Molyneux |Sean Finan |Hannah Edmonds Camara |Paul Mertenskötter
On January 17, 2024, the European Parliament formally endorsed its provisional agreement with the Council on the Directive Empowering Consumers for the Green Transition through Better Protection against Unfair Practices and Better Information (“Greenwashing Directive”). The Council is now expected to endorse the provisional agreement after which the Directive will be published in the EU Official Journal and enter into force.
-
Dec 15, 2023 | 
lexblog.com | Candido Garcia Molyneux |Daniel Feldman |Bart Van Vooren |Paul Mertenskötter
Drawing on his prior positions in government service spanning multiple Administrations, former Ambassador Dan Feldman’s practice focuses on environmental, social, and governance (ESG) counseling, business and human rights (BHR), global public policy, as well as broader international regulatory compliance. He is a member of the firm’s Global Problem Solving initiative.
-
Sep 13, 2023 | 
lexblog.com | Bart Van Vooren |Yuliya Gevrenova |Inga-Marlene Pietsch |Max Jerman
Today, the World Intellectual Property Organization (“WIPO”) finished the preparatory session for the draft International Legal Instrument Relating to Intellectual Property, Genetic Resources and Traditional Knowledge Associated with Genetic Resources (the “Instrument”), which will be discussed and adopted at a diplomatic conference in 2024.
